Skip to main content

Table 3 Changes in baseline characteristics seen after treatment with metoprolol.

From: Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study

  Before metoprolol
(N = 10)
After metoprolol
(N = 10)
% Change after treatment P-value
Body weight (kg) 97.9 ± 5.76 99.7 ± 5.88 1.8% 0.02
BMI (Kg/m²) 32.22 ± 1.84 32.84 ± 1.95 1.9% 0.03
Systolic BP (mm Hg) 143.4 ± 5.12 142.8 ± 5.56 -0.4% 0.90
Diastolic BP (mm Hg) 70.5 ± 4.67 64 ± 3.84 -9.2% 0.04
Heart rate (beats/min) 69.4 ± 3.31 65.5 ± 6.74 -5.6% 0.01
Fasting glucose (mmol/L) 8.53 ± 0.99 8.67 ± 1.14 1.6% 0.90
Fasting insulin (μU/L) 10.82 ± 2.14 14.83 ± 4.75 37.1% 0.60
Hb A1c (%) 7.29 ± 0.42 7.51 ± 0.62 3.0% 0.77
Total Cholesterol (mmol/L) 3.93 ± 0.25 3.81 ± 0.27 -3.1% 0.59
LDL (mmol/L) 2.25 ± 0.27 1.99 ± 0.32 -11.6% 0.17
HDL (mmol/L) 1.09 ± 0.10 1.06 ± 0.12 -2.8% 0.10
TG (mmol/L) 1.33 ± 0.26 1.71 ± 0.35 28.6% 0.04
CRP (mmol/L) 6.80 ± 2.38 4.56 ± 1.56 -32.9% 0.19
  1. T2DM: Patients with Type 2 Diabetes; M/F: Male/Female; ACE inhibitors: Angiotensin Converting Enzyme inhibitors; AT2B: Angiotensin 2 Blockers; BMI: Body Mass Index, BP: Blood Pressure; Hb A1c: Glycosylated Hemoglobin A1c; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein; TG: TriGlyceride; CRP: C-Reactive Protein.